The global Next-generation sequencing (NGS) services market is poised for significant growth, projected to expand from USD 3.80 billion in 2025 to USD 8.77 billion by 2030, registering a robust CAGR of 18.2% during the forecast period.
Download PDF Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=194102241
The growth of the market is primarily driven by the increasing global burden of cancer and the expansion of rare disease research programs. These trends are accelerating the demand for rapid, high-quality sequencing services across both clinical and translational research settings. Additionally, declining sequencing costs have made large-scale genomic studies more accessible, enabling higher testing volumes and broader adoption across healthcare and research institutions.
Population-scale genomics programs and national sequencing initiatives are further contributing to market expansion, generating consistent demand for outsourced sequencing services and advanced bioinformatics analysis. These initiatives are fostering long-term partnerships between service providers and healthcare systems worldwide.
Sequencing Services Segment Leads Market Share
By service type, the market is segmented into sequencing services, pre-sequencing services, bioinformatics services, and platform services. Among these, sequencing services dominated the market in 2024, driven by high-throughput project volumes in oncology, rare diseases, reproductive health, and infectious disease surveillance. The ability to deliver scalable and rapid sequencing results continues to position this segment at the forefront.
Diagnostics Application to Witness Highest Growth
In terms of application, the diagnostics segment accounted for the largest market share and is expected to register the highest CAGR through 2030. The increasing adoption of genomic testing in oncology, hereditary diseases, and infectious disease diagnostics is a key growth driver. Technologies such as tumor profiling and comprehensive genomic profiling (CGP), along with the growing role of companion diagnostics in targeted therapies, are significantly boosting demand.
Speak To Analyst:- https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=194102241
Asia Pacific Emerges as Fastest-Growing Region
Geographically, the Asia Pacific region is projected to witness the fastest growth during the forecast period. Countries such as China, Japan, and India are rapidly scaling their genomic capabilities. China, in particular, is emerging as a major growth engine due to high clinical testing volumes, strong hospital infrastructure, and increasing outsourcing of sequencing services. The expansion of biopharmaceutical R&D and clinical trials in the region is further driving repeat demand for sequencing and data analysis services.
Competitive Landscape
Key players operating in the NGS services market include Illumina, Inc., Thermo Fisher Scientific, and Eurofins Scientific, among others. These companies are focusing on expanding their service portfolios, enhancing sequencing capabilities, and strengthening their global presence to capitalize on emerging opportunities.
